CEO: Daniel de Boer

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: ProQR Therapeutics NV is a biopharmaceutical company engaged in the discovery & development of RNA-based therapeutics for the treatment of severe genetic disorders.


Key numbers

Market Capitalization:340138630
Shares Outstanding: 49367000
Float: 40363644.008
Next Earning Date:2020-02-26
TTm EPS: -1.4773
TTm Dividend Rate:
200 days moving average:10.25
50 days moving average: 6.83
One day percent Change: 15.47



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,